3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
AssigneeParion Sciences, Inc.
InventorMichael R. Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates compounds of the formula: or pharmaceutically acceptable salts thereof, useful as sodium channel blockers, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including cystic fibrosis, chronic obstructive pulmonary disease, asthma, bronchiectasis, acute and chronic bronchitis, emphysema, and pneumonia.
Claims24
A method for blocking sodium channels in a subject or a cell comprising administering to the subject or cell a compound of the formula:
- or a pharmaceutically acceptable salt thereof, wherein:
- Ar is a moiety selected from the group of:
- X is selected from —CH2—, —O—, and —S—;
- R1 and R2 are independently selected from H and C1-C6 alkyl;
- or R1 and R2 together with the nitrogen atom to which they are bound form a 5-membered or 6-membered heterocyclic ring optionally containing one additional ring heteroatom selected from N and O;
- R3 is an alkyl group having from 3 to 8 carbon atoms or a polyhydroxylated alkyl group having from 3 to 8 carbon atoms;
- R4 is a polyhydroxylated alkyl group having from 3 to 8 carbon atoms;
- and
- R5 is selected from H and C1-C3 alkyl.
A method for blocking sodium channels in a subject or a cell comprising administering to the subject or cell a compound selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.